Patents by Inventor Shankar Reddy BUDIDETI

Shankar Reddy BUDIDETI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240376102
    Abstract: The present invention relates to an improved process for the preparation of Ruxolitinib phosphate (1) using novel intermediate compound of Formula (14). The present invention also relates to a process for the preparation of intermediate compound of Formula (14).
    Type: Application
    Filed: September 16, 2022
    Publication date: November 14, 2024
    Inventors: Satya Srinivas HANUMARA, Shankar Reddy BUDIDETI, Srinivasa Krishna KONDURI, Sunitha KOTHAMUNIREDDY GARI, Raji Reddy SOLIPURAM, Jayakrishna KASUGANTI, Ankama Nayudu ANNADASU, Venkateswarlu BANDLA, Lakshmana Viswa Venkata Pavan Kumar MADDULA, Pulla Reddy MUDDASANI, Venkaiah Chowdary NANNAPANENI
  • Publication number: 20240352039
    Abstract: The present invention is related to novel crystalline polymorph. Form-N of Lurbinectedin and process for preparation of Lurbinectedin.
    Type: Application
    Filed: August 30, 2022
    Publication date: October 24, 2024
    Inventors: Srinivasa Chary CHINTALAPATI, Thirupathi KOTTE, Srinivasan ABAYEE KALIYAPERUMAL, Shankar Reddy BUDIDETI, Pulla Reddy MUDDASANI, Venkaiah Chowdary NANNAPANENI
  • Publication number: 20240294549
    Abstract: The present invention is related to novel process for preparation of Trabectedin which involves less expensive reagents, solvents and the process conditions can be easily adopted for commercial scale.
    Type: Application
    Filed: August 30, 2022
    Publication date: September 5, 2024
    Inventors: Sunitha KOTHAMUNIREDDYGARI, Anitha GATTU, Rajireddy SOLIPURAM, Srinivasa Chary CHINTALAPATI, Thirupathi KOTTE, Veerababu MADALAPU, Shankar Reddy BUDIDETI, Pulla Reddy MUDDASANI, Venkaiah Chowdary NANNAPANENI
  • Publication number: 20230081911
    Abstract: The present invention relates to an improved and industrially viable process for the preparation of Acalabrutinib and its Intermediates. The present invention involves less expensive reagents, solvents and the process conditions can be easily adopted for commercial scale. The present invention relates to process for the preparation Acalabrutinib of formula (1) and process for the preparation of Acalabrutinib key starting material.
    Type: Application
    Filed: December 1, 2020
    Publication date: March 16, 2023
    Inventors: Shankar Reddy BUDIDETI, Srinivasa Krishna Murthy KONDURI, Jagan Mohan Reddy SANAPUREDDY, Ravi Kumar REMELLA, Sandeep Kumar THOOTA, Sunitha KOTHAMUNIREDDYGARI, Pulla Reddy MUDDASANI, Venkaiah Chowdary NANNAPANENI
  • Patent number: 11091470
    Abstract: Present invention relates to an improved process for the preparation of N—(3-ethynylphenyl)-7-methoxy-6-(3-morpholinopropoxy) quinazolin-4-amine dihydrochloride of formula-I.
    Type: Grant
    Filed: June 19, 2017
    Date of Patent: August 17, 2021
    Assignee: NATCO PHARMA LIMITED
    Inventors: Pulla Reddy Muddasani, Shankar Reddy Budideti, Srinivasa Krishna Murthy Konduri, Nagalingam Samatham, Venkaiah Chowdary Nannapaneni
  • Publication number: 20200331899
    Abstract: Present invention relates to an improved process for the preparation of N-(3-ethynylphenyl)-7-methoxy-6-(3-morpholinopropoxy) quinazolin-4-amine dihydrochloride of formula-I.
    Type: Application
    Filed: June 19, 2017
    Publication date: October 22, 2020
    Inventors: Pulla Reddy MUDDASANI, Shankar Reddy BUDIDETI, Srinivasa Krishna Murthy KONDURI, Nagalingam SAMATHAM, Venkaiah Chowdary NANNAPANENI
  • Patent number: 10626117
    Abstract: The present invention relates to an improved process for the preparation of Ibrutinib with high purity and high yields. The present process is cost effective and feasible in large scale production also. The present process avoids the mitsunobu reagent conditions also. The present Invention also relates to a process for the preparation of Crystalline form A and Crystalline form C of Ibrutinib.
    Type: Grant
    Filed: February 1, 2017
    Date of Patent: April 21, 2020
    Assignee: NATCO PHARMA LIMITED
    Inventors: Pulla Reddy Muddasani, Shankar Reddy Budideti, Veerababu Madalapu, Anitha Gattu, Bala Ankireddy Konda, Venkaiah Chowdary Nannapaneni
  • Publication number: 20190300484
    Abstract: The present invention relates to an improved process for the preparation of Regorafenib with genotoxic impurities at well below threshold limit and high yield. The present invention also relates to an improved process for the preparation of regorafenib form-I with high purity.
    Type: Application
    Filed: March 31, 2016
    Publication date: October 3, 2019
    Inventors: Pulla Reddy MUDDASANI, Shankar Reddy BUDIDETI, Srinivasachary CHINTALAPATI, Tirupathi KOTTE, Sambasiva Rao TALASILA, Venkaiah Chowdary NANNAPANENI
  • Publication number: 20190241567
    Abstract: The present invention relates to an improved process for the preparation of Ibrutinib with high purity and high yields. The present process is cost effective and feasible in large scale production also. The present process avoids the mitsunobu reagent conditions also. The present Invention also relates to a process for the preparation of Crystalline form A and Crystalline form C of Ibrutinib.
    Type: Application
    Filed: February 1, 2017
    Publication date: August 8, 2019
    Inventors: Pulla Reddy MUDDASANI, Shankar Reddy BUDIDETI, Veerababu MADALAPU, Anitha GATTU, Bala Ankireddy KONDA, Venkaiah Chowdary NANNAPANENI